Tamsulosin Assisted Ureteral Access Sheath Insertion

Medication Facilitated Ureteral Access Sheath Deployment During Ureteroscopy: the Impact of One Week of Pre-operative Tamsulosin

NCT05197088•Sengkang General Hospital

View on ClinicalTrials.gov

Summary

Aim is to study if 1 week of pre operative tamsulosin would enable easier insertion of ureteral access sheath in primary retrograde intrarenal surgery for renal stone disease

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•renal stone undergoing retrograde intrarenal surgery

Exclusion Criteria

•not on tamsulosin or other alpha blockers regularly
•ureteral stricture
•concurrent ureteric stone

Key Dates

Start Date

January 9, 2022

Primary Completion Date

March 31, 2023

Completion Date

July 31, 2023

Last Updated

January 19, 2022

Enrollment

110

ESTIMATED participants

Conditions

Renal StoneRetrograde Intrarenal SurgeryUrolithiasis

Interventions

Tamsulosin

DRUG

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent

NCT07275879

Ureteral Double-J StentUrolithiasis+1 more

View study

RECRUITINGPHASE1/PHASE2

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

NCT06158620

Post Operative PainUrolithiasis+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 19, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Tamsulosin Assisted Ureteral Access Sheath Insertion

Inclusion Criteria

Exclusion Criteria

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

Renal Stone Treatment Global Registry

Multiomics Biomarkers for Urolithiasis

Effect of Preoperative Silodosin on Feasibility of Ureteral Access Sheath Insertion

Registry of MIUS for Urolithiasis (ReMIUS-U)